The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. 2014

R Kang, and D Tang, and N E Schapiro, and T Loux, and K M Livesey, and T R Billiar, and H Wang, and B Van Houten, and M T Lotze, and H J Zeh
Department of Surgery, Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.

Tumor cells require increased adenosine triphosphate (ATP) to support anabolism and proliferation. The precise mechanisms regulating this process in tumor cells are unknown. Here, we show that the receptor for advanced glycation endproducts (RAGE) and one of its primary ligands, high-mobility group box 1 (HMGB1), are required for optimal mitochondrial function within tumors. We found that RAGE is present in the mitochondria of cultured tumor cells as well as primary tumors. RAGE and HMGB1 coordinately enhanced tumor cell mitochondrial complex I activity, ATP production, tumor cell proliferation and migration. Lack of RAGE or inhibition of HMGB1 release diminished ATP production and slowed tumor growth in vitro and in vivo. These findings link, for the first time, the HMGB1-RAGE pathway with changes in bioenergetics. Moreover, our observations provide a novel mechanism within the tumor microenvironment by which necrosis and inflammation promote tumor progression.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011500 Protein Synthesis Inhibitors Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. Protein Synthesis Antagonist,Protein Synthesis Antagonists,Protein Synthesis Inhibitor,Antagonist, Protein Synthesis,Antagonists, Protein Synthesis,Inhibitor, Protein Synthesis,Inhibitors, Protein Synthesis,Synthesis Antagonist, Protein,Synthesis Inhibitor, Protein
D002070 Butadienes Four carbon unsaturated hydrocarbons containing two double bonds. Butadiene Derivative,Butadiene Derivatives,Derivative, Butadiene,Derivatives, Butadiene
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide

Related Publications

R Kang, and D Tang, and N E Schapiro, and T Loux, and K M Livesey, and T R Billiar, and H Wang, and B Van Houten, and M T Lotze, and H J Zeh
January 2019, OncoTargets and therapy,
R Kang, and D Tang, and N E Schapiro, and T Loux, and K M Livesey, and T R Billiar, and H Wang, and B Van Houten, and M T Lotze, and H J Zeh
September 2023, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
R Kang, and D Tang, and N E Schapiro, and T Loux, and K M Livesey, and T R Billiar, and H Wang, and B Van Houten, and M T Lotze, and H J Zeh
June 2014, Oncology reports,
R Kang, and D Tang, and N E Schapiro, and T Loux, and K M Livesey, and T R Billiar, and H Wang, and B Van Houten, and M T Lotze, and H J Zeh
October 2022, Nature chemical biology,
R Kang, and D Tang, and N E Schapiro, and T Loux, and K M Livesey, and T R Billiar, and H Wang, and B Van Houten, and M T Lotze, and H J Zeh
December 2015, Antioxidants & redox signaling,
R Kang, and D Tang, and N E Schapiro, and T Loux, and K M Livesey, and T R Billiar, and H Wang, and B Van Houten, and M T Lotze, and H J Zeh
January 2022, Computational intelligence and neuroscience,
R Kang, and D Tang, and N E Schapiro, and T Loux, and K M Livesey, and T R Billiar, and H Wang, and B Van Houten, and M T Lotze, and H J Zeh
October 2023, Archives of biochemistry and biophysics,
R Kang, and D Tang, and N E Schapiro, and T Loux, and K M Livesey, and T R Billiar, and H Wang, and B Van Houten, and M T Lotze, and H J Zeh
April 2018, Taiwanese journal of obstetrics & gynecology,
R Kang, and D Tang, and N E Schapiro, and T Loux, and K M Livesey, and T R Billiar, and H Wang, and B Van Houten, and M T Lotze, and H J Zeh
January 2023, Computational intelligence and neuroscience,
R Kang, and D Tang, and N E Schapiro, and T Loux, and K M Livesey, and T R Billiar, and H Wang, and B Van Houten, and M T Lotze, and H J Zeh
February 2022, Clinics and research in hepatology and gastroenterology,
Copied contents to your clipboard!